Results for "Novo Nordisk"

Keyword scan across titles, descriptions, summaries, and tags. For interview listings, try Guest appearances.

10 results

Episodes

  • Acquired
    StandardSummaries only

    Novo Nordisk (Ozempic)

    Acquired· Ben Gilbert· Jan 22, 2024

    Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became …

    investing
  • Dividend Talk
    StandardSummaries only

    EPS #278 | Building Wealth Together: Our Community Portfolio Review | + Novo Nordisk News, Rio Tinto & Glencore Merger, Terry Smith's Annual Shareholder Letter,

    Dividend Talk· Jan 10, 2026

    In this episode of the Dividend Talk podcast, we review the performance of their Community Dividend Growth Portfolio, discuss Novo Nordisk's news, the Rio Tinto & Glencore Merger, Terry Smiths Fundsmith annual shareholde…

    investing
  • Dividend Talk
    StandardSummaries only

    EPS #269 | Novo Nordisk Earnings, Kimberly-Clark Buys Kenvue, & Our Update on monthly dividend portfolio

    Dividend Talk· Nov 8, 2025

    In this week’s episode of Dividend Talk we kick off with Kimberly-Clark’s surprise move to buy Kenvue, asking if it’s a smart acquisition or a future balance-sheet headache. Then we review Q3 earnings from Novo Nordisk, …

    aiinvesting
  • The Jaeden Schafer Podcast
    Intelligent Report

    Anthropic's IPO Play, Novo Nordisk x OpenAI, and the First Brain Sensor Goes Human

    The Jaeden Schafer Podcast· Apr 15, 2026

    Zuckerberg's AI clone, Apple's smart glasses, Vercel's IPO readiness, Anthropic drama, banks testing a dangerous AI model, and a Molotov cocktail attack on Sam Altman's home.

    openaianthropic
  • Dividend Talk
    StandardSummaries only

    Eps 262 | 4 Reliable Dividend Stocks for September 2025

    Dividend Talk· Sep 5, 2025

    Derek and Edgi share four safe dividend stocks for September ,Accenture, Fuchs Petrolub, Canadian Natural Resources, and Munich Re. They also cover market news on Sanofi, Novo Nordisk, and T. Rowe Price, discuss dividend…

    investing
  • Dividend Talk
    StandardSummaries only

    EPS 276| 2025 Year in Review & Crazy Predictions for 2026

    Dividend Talk· Dec 26, 2025

    We wrap up 2025 with a full Dividend Talk year-in-review, reflecting on the biggest investing lessons, most discussed stocks, and the questions that mattered most to dividend growth investors.In this episode, we cover:• …

    investing
  • Dividend Talk
    StandardSummaries only

    EPS 267 | Q3 Earnings and should we be worried about Evolution Gaming

    Dividend Talk· Oct 24, 2025

    In this week’s episode of Dividend Talk, we’re back with Q3 Earnings Roundup.We kick things off with Novo Nordisk shaking up half its board of directors, before covering two big dividend announcements from McDonald’s and…

    investing
  • Dividend Talk
    StandardSummaries only

    Growth Investor Turned Dividend Investor from Heavy Moat Investment| Ep 308

    Dividend Talk· Sep 25, 2026

    Niklas from Heavy Moat Investments is back. Last time he barely cared about dividends. Now 80% of his portfolio pays one. We talk about how becoming a dad changed the way he looks at risk, why he raised his hurdle rate t…

    investing
  • Dividend Talk
    StandardSummaries only

    How to Find US & European Dividend Growth Stocks | Insurance Dividend Boom, Novo Nordisk & AI Risks | EPS 285

    Dividend Talk· Mar 1, 2026

    How do you consistently find high-quality US and European dividend growth stocks? In Episode 285, we revisit our original stock screening framework and update it for today’s market environment including AI disruption, in…

    aiinvesting
  • Dividend Talk
    StandardSummaries only

    Eps 264| How We Handle Drawdowns in Dividend Growth Investing

    Dividend Talk· Sep 20, 2025

    In this episode, we dive into the realities of dealing with portfolio drawdowns as dividend growth investors. From personal examples to strategies for averaging down, price anchoring, and knowing when to hold or sell, we…

    investing